March 5th 2025
The partnership will advance the accessibility, scalability, and affordability of RNA-based vaccines.
J&J to Supply the African Union with 200 Million Doses of its COVID-19 Vaccine
March 29th 2021The company has entered into an agreement with the African Vaccine Acquisition Trust for the supply of 220 million doses of its single-shot COVID-19 vaccine for the African Union’s 55 member states beginning in the third quarter of 2021.
Catalent to Increase Manufacturing Capacity at Italian Facility for J&J COVID-19 Vaccine
March 18th 2021Under an expanded agreement with J&J, Catalent Biologics will increase manufacturing capacity at its Anagni, Italy, site to accommodate the large-scale commercial supply of Janssen’s COVID-19 vaccine.
COVID-19 Vaccine Makers Overcome Challenges to Ramp Up Production
March 1st 2021To prevent future production delays of critical products, the Biden administration is examining supply chain vulnerabilities for pharmaceutical ingredients as part of a longer-range consideration of products important to public health.
Sanofi to Support the Manufacturing of Janssen’s Single-Dose COVID-19 Vaccine
February 22nd 2021Once the vaccine has been authorized, Sanofi will provide Johnson & Johnson with access to its vaccine manufacturing plant in Marcy l’Etoile, France, to formulate and fill vials of the vaccine, at a rate of 12 million doses per month.